ARTICLE | Company News
Ovation, Lundbeck deal
June 21, 2004 7:00 AM UTC
Ovation acquired global rights to Buronil melperone hydrochloride from LUN to treat schizophrenia and other CNS conditions. The product already is marketed in 12 European countries. Ovation will seek ...